Nuwellis, Inc. (NUWE)

Market Cap	4.77M
Revenue (ttm)	8.90M
Net Income (ttm)	-19.93M
Shares Out	18.05M
EPS (ttm)	-7.37
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,230,691
Open	0.300
Previous Close	0.274
Day's Range	0.252 - 0.319
52-Week Range	0.130 - 3.830
Beta	0.30
Analysts	Hold
Price Target	n/a
Earnings Date	May 7, 2024

About NUWE

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Aus...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 59
• Stock Exchange: NASDAQ
• Ticker Symbol: NUWE

Financial Performance

In 2023, Nuwellis's revenue was $8.86 million, an increase of 3.76% compared to the previous year's $8.54 million. Losses were -$22.63 million, 55.8% more than in 2022.